VIVE - Viveve Medical GAAP EPS of -$0.67 in-line revenue of $1.8M beats by $0.04M August, 11 2022 04:16 PM Viveve Medical Inc. Viveve Medical press release ( NASDAQ: VIVE ): Q2 GAAP EPS of -$0.67 in-line. Revenue of $1.8M (+9.1% Y/Y) beats by $0.04M . For further details see: Viveve Medical GAAP EPS of -$0.67 in-line, revenue of $1.8M beats by $0.04M